Figure 1 | Genetics in Medicine

Figure 1

From: Correction: Effectiveness of plasma lyso-Gb3 as a biomarker for selecting high-risk patients with Fabry disease from multispecialty clinics for genetic analysis

Figure 1

a Female Positive (n = 15) was replaced with (n = 14), and we deleted the dot plot for one female patient in the positive group (plasma lyso-Gb3 7.6 ng ml−1). Therefore, the median plasma lyso-Gb3 value of Female Positive was changed from “11.5 ng ml−1” to “13.3 ng ml−1.” The position of short horizontal line was also changed. b Female Positive (n = 15) was replaced with (n = 14), and we deleted the dot plot for one female patient in the positive group (plasma α-Gal A activity 4.9 nmol h−1 ml−1). Therefore, the median plasma α-Gal A activity value of Female Positive was changed from “4.6 nmol h−1 ml−1” to “3.9  nmol h−1 ml−1.” The position of the short horizontal line was also changed.

Back to article page